Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Signogard 35mg Tablet MR

Prescription Icon
Prescription Required

Marketer

Signova Pharma Pvt Ltd

Salt Composition

Trimetazidine (35mg)

Overview Signogard 35mg Tablet MR

Cardiogard 35mg Extended-Release Tablets are prescribed for angina pectoris, a type of chest discomfort stemming from heart issues. This medication acts as a preventative measure against angina episodes; however, it's ineffective in halting an attack already in progress. It may be administered independently or alongside other cardiac medications, as determined by your physician. Consistent daily use, as directed, is crucial. Consumption with or without food is acceptable, maintaining a consistent schedule. Dosage frequency is subject to adjustment based on therapeutic response. Continuous use is vital for optimal effect, even during symptom-free periods, mitigating future cardiac events. Discontinuation may lead to a recurrence of angina. Lifestyle modifications such as smoking cessation, moderate alcohol consumption, balanced nutrition, regular physical activity, and stress management significantly contribute to cardiovascular well-being. Potential side effects include vertigo, cephalalgia, stomach upset, bowel irregularities, dyspepsia, nausea, emesis, dermatological reactions (rash, pruritus, urticaria), and asthenia. Report any persistent or bothersome adverse reactions to your doctor. Pre-existing liver or kidney conditions, pregnancy, breastfeeding, and concurrent medication use should be disclosed to your physician before commencing treatment to ensure suitability.

Primary Ingredients of Signogard 35mg Tablet MR

No information provided. Please provide the text you wish to be rewritten.

Uses of Signogard 35mg Tablet MR

Managing chest pain associated with angina pectoris

Major Benefits of Signogard 35mg Tablet MR:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Signogard 35mg Modified-Release tablet should be taken with a meal.

Common Side effects of Signogard 35mg Tablet MR:

  • Dizziness
  • Headache
  • Nausea
  • Vomiting
  • Weakness
  • Rash
  • Abdominal pain
  • Indigestion
  • Itching
  • Diarrhea
  • Hives

How to use Signogard 35mg Tablet MR:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the entire tablet; do not crush, chew, or fracture it. Signogard 35mg Modified-Release Tablets should be administered with a meal.

How Signogard 35mg Tablet MR works:

Signogard 35mg Modified-Release tablets are used to treat angina. They achieve this by altering the heart's energy source, favoring glucose over fatty acids, thereby reducing the heart's oxygen demand and improving its overall function.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent use of Signogard 35mg Modified-Release tablets and alcohol may result in heightened somnolence.

PregnancyPregnancyCONSULT YOUR DOCTOR

Pregnancy-related data on the use of Signogard 35mg MR tablets is absent. Seek medical advice from your physician.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Data on Signogard 35mg MR Tablet use while breastfeeding is lacking. Seek medical advice from your physician.

DrivingDrivingUNSAFE

Taking Signogard 35mg Modified-Release tablets might reduce attentiveness, impair vision, or cause drowsiness and dizziness. Refrain from driving if you experience these effects.

KidneyKidneyCAUTION

Patients with impaired kidney function should use Signogard 35mg Modified-Release Tablets cautiously, potentially requiring dosage modification. Consult a physician before use. Signogard 35mg Modified-Release Tablets are contraindicated in individuals with severe renal insufficiency.

LiverLiverCONSULT YOUR DOCTOR

Insufficient data exists regarding the use of Signogard 35mg modified-release tablets in individuals with hepatic impairment. Physician consultation is advised.

What if you forget to take Signogard 35mg Tablet MR :

Should you forget a Signogard 35mg MR Tablet dose, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.

Facts to Know About Signogard 35mg Tablet MR

LabelValue
Chemical Category Benzylamines
Developing Habits No.
Treatment Category Heart
Action Class Fatty acid and sodium channel modulator

FAQs on Signogard 35mg Tablet MR

Signogard 35mg MR tablets are not beta-blockers. This anti-anginal medication, used alongside other treatments, helps manage angina pectoris (chest pain from coronary artery disease) by shielding heart cells from oxygen deprivation during angina attacks.
Avoid Signogard 35mg Tablet MR if you're allergic to it, have severe kidney disease, or have Parkinson's disease. Parkinson's disease is a brain disorder affecting movement, causing tremors, rigidity, slow movement, and an unsteady gait.
For patients over 75, Signogard 35mg MR tablets require careful administration. Lower doses are typically prescribed to minimize adverse reactions, necessitating close monitoring.
Signogard 35mg Tablet MR may rarely cause falls, possibly due to gait instability or postural hypotension. Elderly patients may be at increased risk and require closer supervision and caution.
Signogard 35mg MR Tablets may cause dizziness or drowsiness. Avoid driving or operating machinery if affected.
Take your Signogard 35mg MR Tablet exactly as directed by your doctor. Swallow the tablet whole with plenty of liquid, such as water. This medication may be taken with or without food.
Signogard 35mg MR tablets may cause dizziness, headache, abdominal pain, diarrhea, indigestion, hives, rash, and itching. Some users experience nausea and weakness. Rare side effects include palpitations, postural hypotension (potentially causing dizziness, lightheadedness, or fainting), falls, and flushing.
Signogard 35mg Tablet MR
297
MRP 344
13% off